Despite the increase in plasma KP and hepatic KISS1/KISS1R levels observed in a mouse model of NAFLD or in livers of patients with NAFLD, the endogenous activation of the KISS1R signaling pathway is clearly not sufficient to safeguard against disease progression. Here, KISS1 is linked to metabolic dysfunction-associated steatotic liver disease.